ruxolitinib,navitoclax,lisocabtagene maraleucel
bms,abbvie,novartis,incyte
['bet', '#mpn', 'ruxolitinib', 'transform-1', 'navitoclax', 'mpnsm', 'refine study', 'myeloid', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)']
#ash22| francesco passamonti, circolo hospital discusses the potential of disease modification with navitoclax and rux combination therapy in pts with mf. 50% of pts achieved a jak2 vaf reduction &gt;20% and 35% of pts a bmf 1-grade improvement.
#mpn #mpnsm #medicalcongress 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm